Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of chiglitazar on endothelial function and carotid intima-media thickness in type 2 diabetes mellitus
ChiCTR2400084909Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Third Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of chiglitazar in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shandong Provincial Third Hospital. Primary endpoints: Endothelial function and Carotid intima-media thickness. Planned start May 2024; status: not yet recruiting.
02
Drugs
chiglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2400084909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084909.